Income Statement bioMérieux

Equities

BIM

FR0013280286

Medical Equipment, Supplies & Distribution

Market Closed - Euronext Paris Other stock markets 16:55:00 16/01/2026 GMT			5-day change	1st Jan Change
104.60 ^EUR	-1.51%		-7.35%	-5.17%

01-07	BioMérieux Slips Despite Intensifying Flu Season Across the Atlantic
12-04	Biomerieux Launches Leading Endocrinology Testing Offer Dedicated to Enhancing Equine Health	CI

eabcffcdfd387365ca6622c8494.-snMbELkLgPrjWsPwapYQguEww2a1B5jDMe-r4vDOGU.k6H8JAXRWkej1Dl9tOxtDj7rnEvjhUYPeZ_sn92NUwG5jPtfMaNHaIXGPg

Published financial data: BIOMÉRIEUX

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2020	2021	2022	2023	2024
Revenues	3.12B	3.38B	3.59B	3.67B	3.98B
Total Revenues	3.12B	3.38B	3.59B	3.67B	3.98B
Cost of Goods Sold, Total	1.36B	1.41B	1.58B	1.62B	1.76B
Gross Profit	1.75B	1.96B	2.01B	2.06B	2.22B
Selling General & Admin Expenses, Total	789M	818M	955M	1.02B	1.1B
R&D Expenses	399M	389M	447M	460M	492M
Depreciation & Amortization - (IS)	-	-	-	40.7M	35.2M
Amortization of Goodwill and Intangible Assets - (IS)	-	-	38M	-	-
Other Operating Expenses	-46.9M	-44.6M	-43.6M	-33M	-46.9M
Other Operating Expenses, Total	1.14B	1.16B	1.4B	1.49B	1.58B
Operating Income	612M	801M	613M	569M	638M
Interest Expense, Total	-24.1M	-9.1M	-4.1M	-4.4M	-16M
Interest And Investment Income	1.5M	1.7M	1.2M	1.1M	14.4M
Net Interest Expenses	-22.6M	-7.4M	-2.9M	-3.3M	-1.6M
Income (Loss) On Equity Invest.	-200K	-700K	-	-	-
Currency Exchange Gains (Loss)	-6.5M	-4.3M	-1.4M	4.7M	-4.3M
Other Non Operating Income (Expenses)	1.3M	1.5M	-2.2M	200K	-3.5M
EBT, Excl. Unusual Items	584M	790M	606M	571M	628M
Merger & Related Restructuring Charges	-	-	-9.6M	-300K	-300K
Impairment of Goodwill	-17.5M	-16.9M	-29M	-94.9M	-
Gain (Loss) On Sale Of Investments	-600K	600K	-	-3.4M	-
Gain (Loss) On Sale Of Assets	-	-	12.8M	-	-
Asset Writedown	-	-	-	-34.7M	-48.8M
Other Unusual Items	-42.2M	-	-	-	-
EBT, Incl. Unusual Items	524M	774M	581M	437M	579M
Income Tax Expense	122M	176M	140M	114M	154M
Earnings From Continuing Operations	403M	598M	441M	323M	425M
Net Income to Company	403M	598M	441M	323M	425M
Minority Interest	1.7M	2.9M	11.8M	34.8M	7.1M
Net Income - (IS)	404M	601M	452M	358M	432M
Net Income to Common Incl Extra Items	404M	601M	452M	358M	432M
Net Income to Common Excl. Extra Items	404M	601M	452M	358M	432M
Per Share Items
Net EPS - Basic	3.42	5.08	3.84	3.03	3.67
Basic EPS - Continuing Operations	3.42	5.08	3.84	3.03	3.67
Basic Weighted Average Shares Outstanding	118M	118M	118M	118M	118M
Net EPS - Diluted	3.41	5.06	3.82	3.01	3.64
Diluted EPS - Continuing Operations	3.41	5.06	3.82	3.01	3.64
Diluted Weighted Average Shares Outstanding	119M	119M	118M	119M	119M
Normalized Basic EPS	3.11	4.2	3.31	3.31	3.4
Normalized Diluted EPS	3.09	4.18	3.3	3.29	3.37
Dividend Per Share	0.62	0.85	0.85	0.85	0.9
Payout Ratio	5.56	12.16	22.37	28.02	-
American Depositary Receipts Ratio (ADR)	0.1	0.1	0.1	0.1	0.1
Supplemental Items
EBITDA	796M	1B	814M	858M	948M
EBITA	661M	860M	696M	691M	740M
EBIT	612M	801M	613M	569M	638M
EBITDAR	-	-	-	-	-
Effective Tax Rate - (Ratio)	23.18	22.69	24.13	26.18	26.63
Total Current Taxes	129M	181M	208M	195M	199M
Total Deferred Taxes	-7.6M	-5.8M	-67.9M	-81M	-44.8M
Normalized Net Income	367M	497M	391M	391M	400M
Interest on Long-Term Debt	2.8M	2.5M	2.8M	4.3M	6.6M
Non-Cash Pension Expense	500K	300K	300K	300K	600K
Supplemental Operating Expense Items
Selling and Marketing Expenses	589M	576M	702M	726M	784M
General and Administrative Expenses	200M	243M	253M	295M	314M
Research And Development Expense From Footnotes	445M	447M	490M	540M	554M
Net Rental Expense, Total	-	-	-	-	-
Imputed Operating Lease Interest Expense	-	-	-	-	-
Imputed Operating Lease Depreciation	-	-	-	-	-
Stock-Based Comp., Other (Total)	9.9M	12.4M	13M	19.7M	23.4M
Total Stock-Based Compensation	9.9M	12.4M	13M	19.7M	23.4M

Fiscal Period: December	2020	2021	2022	2023	2024
Assets
Cash And Equivalents	389M	804M	553M	352M	450M
Total Cash And Short Term Investments	389M	804M	553M	352M	450M
Accounts Receivable, Total	598M	591M	740M	729M	792M
Other Receivables	84.2M	111M	117M	132M	146M
Total Receivables	682M	701M	857M	860M	939M
Inventory	542M	635M	737M	908M	1.04B
Prepaid Expenses	20.7M	23.9M	31.4M	38.6M	33M
Other Current Assets, Total	27.7M	43.7M	38.8M	45.4M	42.3M
Total Current Assets	1.66B	2.21B	2.22B	2.21B	2.5B
Gross Property Plant And Equipment	2.17B	2.45B	2.7B	2.95B	3.32B
Accumulated Depreciation	-1.1B	-1.22B	-1.33B	-1.44B	-1.63B
Net Property Plant And Equipment	1.07B	1.22B	1.37B	1.51B	1.7B
Long-term Investments	39.9M	34.5M	71.2M	206M	180M
Goodwill	629M	670M	812M	699M	730M
Other Intangibles, Total	431M	412M	625M	529M	492M
Accounts Receivable Long-Term	14.3M	12.6M	12.9M	7.7M	9.1M
Loans Receivable Long-Term	8M	24.7M	17.1M	14.2M	15.6M
Deferred Tax Assets Long-Term	72.6M	29.1M	58.7M	92.7M	146M
Other Long-Term Assets, Total	2.7M	3M	2.6M	-	100K
Total Assets	3.93B	4.62B	5.19B	5.26B	5.77B
Liabilities
Accounts Payable, Total	207M	240M	269M	265M	272M
Accrued Expenses, Total	327M	318M	373M	379M	452M
Short-term Borrowings	17.9M	26.3M	53.9M	29M	17.7M
Current Portion of Long-Term Debt	86.5M	48.6M	107M	107M	94.4M
Current Portion of Leases	24.5M	24.8M	26.2M	27.4M	29.4M
Current Income Taxes Payable	44.3M	67.4M	49M	52.8M	35.4M
Unearned Revenue Current, Total	68.7M	84M	88.5M	80.1M	87.4M
Other Current Liabilities	148M	147M	164M	147M	147M
Total Current Liabilities	924M	956M	1.13B	1.09B	1.13B
Long-Term Debt	249M	265M	225M	234M	207M
Long-Term Leases	103M	97.6M	93.7M	121M	143M
Deferred Tax Liability Non Current	106M	61.1M	53M	11.1M	25.7M
Other Non Current Liabilities	64.4M	62.6M	41.2M	53.2M	49.2M
Total Liabilities	1.45B	1.44B	1.54B	1.51B	1.56B
Common Stock, Total	12M	12M	12M	12M	12M
Additional Paid In Capital	63.7M	63.7M	3.06B	3.42B	3.67B
Retained Earnings	1.05B	1.21B	452M	358M	432M
Treasury Stock	-23M	-10.3M	-36M	-19.1M	-42.9M
Comprehensive Income and Other	1.32B	1.85B	114M	-18.5M	137M
Total Common Equity	2.43B	3.12B	3.6B	3.75B	4.2B
Minority Interest	50.2M	51.4M	38.7M	-	6.1M
Total Equity	2.48B	3.17B	3.64B	3.75B	4.21B
Total Liabilities And Equity	3.93B	4.62B	5.19B	5.26B	5.77B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	118M	118M	118M	118M	118M
ECS Total Common Shares Outstanding	118M	118M	118M	118M	118M
Book Value / Share	20.58	26.41	30.54	31.76	35.66
Tangible Book Value	1.37B	2.04B	2.17B	2.52B	2.98B
Tangible Book Value Per Share	11.6	17.27	18.36	21.37	25.29
Total Debt	481M	462M	505M	519M	491M
Net Debt	92.1M	-341M	-47.2M	166M	40.9M
Debt Equivalent of Unfunded Proj. Benefit Obligation	35.4M	34.6M	12.5M	20.2M	23.3M
Debt Equivalent Oper. Leases	-	-	-	-	-
Minority Interest, Total (Incl. Fin. Div)	50.2M	51.4M	38.7M	-	6.1M
Equity Method Investments, Total	-	900K	900K	800K	800K
Account Code - Inventory Valuation	5	5	5	5	5
Inventories - Raw Materials, Total	216M	264M	326M	385M	419M
Inventories - Work In Process, Total	56.3M	51.7M	89.8M	99.8M	110M
Inventories - Finished Goods, Total	312M	362M	364M	470M	546M
Land - (BS)	51.3M	54.5M	56.5M	58.5M	63.6M
Buildings, Total	646M	743M	824M	846M	954M
Machinery, Total	949M	626M	682M	785M	808M
Full Time Employees	12.32K	12.08K	12.56K	13.41K	14.15K
Part Time Employees	307	295	578	573	607
Assets under Capital Lease - Gross	-	-	-	-	-
Assets under Capital Lease - Accumulated Depreciation	-	-	-	-	-
Accumulated Allowance for Doubtful Accounts (Supple)	34.2M	43.1M	47.7M	51.7M	33.7M

Fiscal Period: December	2020	2021	2022	2023	2024
Net Income	404M	601M	452M	358M	432M
Depreciation & Amortization - CF	160M	172M	147M	196M	242M
Amortization of Goodwill and Intangible Assets - (CF)	48.4M	59.4M	82.7M	122M	102M
Depreciation & Amortization, Total	209M	231M	230M	318M	344M
Amortization of Deferred Charges, Total - (CF)	19.6M	16.9M	18.1M	15.7M	16.3M
(Gain) Loss on Sale of Investments - (CF)	600K	-600K	-	-	-
Asset Writedown & Restructuring Costs	17.5M	16.9M	29M	130M	22.9M
(Income) Loss On Equity Investments - (CF)	200K	700K	-	-	-
Stock-Based Compensation (CF)	9.9M	12.4M	13M	19.7M	23.4M
Other Operating Activities, Total	2.5M	-30.8M	-111M	-192M	-121M
Change In Accounts Receivable	-80.4M	23.6M	-146M	-13.7M	-53.7M
Change In Inventories	-82.9M	-62.4M	-92.1M	-193M	-85.1M
Change In Accounts Payable	4.7M	24.2M	9.9M	3.4M	-600K
Change in Other Net Operating Assets	77.9M	-21.8M	71.9M	-400K	88.4M
Cash from Operations	583M	811M	475M	445M	667M
Capital Expenditure	-278M	-290M	-287M	-338M	-346M
Sale of Property, Plant, and Equipment	24.7M	20M	17.4M	6.4M	9.4M
Cash Acquisitions	-10.1M	-36.8M	-205M	-	-8.8M
Divestitures	-	-	-	-	-
Investment in Marketable and Equity Securities, Total	-2.3M	-400K	-53.8M	-157M	-14.6M
Cash from Investing	-265M	-307M	-528M	-489M	-360M
Long-Term Debt Issued, Total	292M	18.2M	67.7M	38.9M	9.8M
Total Debt Issued	292M	18.2M	67.7M	38.9M	9.8M
Long-Term Debt Repaid, Total	-426M	-68.3M	-53.4M	-73.7M	-84.6M
Total Debt Repaid	-426M	-68.3M	-53.4M	-73.7M	-84.6M
Issuance of Common Stock	-	-	-	12.7M	-
Repurchase of Common Stock	-18.4M	-3.8M	-157M	-	-37.6M
Common Dividends Paid	-22.5M	-73.1M	-101M	-100M	-
Common & Preferred Stock Dividends Paid	-22.5M	-73.1M	-101M	-100M	-
Other Financing Activities, Total	-800K	-	-100K	-	-100M
Cash from Financing	-176M	-127M	-244M	-122M	-213M
Foreign Exchange Rate Adjustments	-34.1M	39.2M	38.7M	-29.7M	13.9M
Miscellaneous Cash Flow Adjustments	-	-	-	100K	-
Net Change in Cash	107M	416M	-258M	-195M	109M
Supplemental Items
Cash Interest Paid	24.9M	9.1M	4.1M	4.4M	16M
Cash Income Tax Paid (Refund)	116M	185M	224M	204M	206M
Levered Free Cash Flow	283M	395M	168M	159M	298M
Unlevered Free Cash Flow	298M	401M	170M	162M	308M
Change In Net Working Capital	45.4M	70.1M	187M	209M	129M
Net Debt Issued / Repaid	-134M	-50.1M	14.3M	-34.8M	-74.8M

Fiscal Period: December	2020	2021	2022	2023	2024
Profitability
Return on Assets	9.93	11.72	7.83	6.81	7.23
Return on Total Capital	13.18	15.17	9.86	8.45	8.89
Return On Equity %	17.01	21.15	12.95	8.73	10.68
Return on Common Equity	17.45	21.64	13.47	9.72	10.86
Margin Analysis
Gross Profit Margin %	56.24	58.16	55.97	55.99	55.66
SG&A Margin	25.31	24.24	26.6	27.77	27.58
EBITDA Margin %	25.54	29.74	22.68	23.34	23.82
EBITA Margin %	21.19	25.48	19.38	18.82	18.59
EBIT Margin %	19.64	23.72	17.08	15.48	16.03
Income From Continuing Operations Margin %	12.91	17.72	12.28	8.78	10.68
Net Income Margin %	12.97	17.8	12.6	9.73	10.86
Net Avail. For Common Margin %	12.97	17.8	12.6	9.73	10.86
Normalized Net Income Margin	11.77	14.71	10.89	10.65	10.05
Levered Free Cash Flow Margin	9.08	11.7	4.67	4.34	7.48
Unlevered Free Cash Flow Margin	9.56	11.87	4.75	4.41	7.73
Asset Turnover
Asset Turnover	0.81	0.79	0.73	0.7	0.72
Fixed Assets Turnover	2.98	2.94	2.77	2.56	2.49
Receivables Turnover (Average Receivables)	5.42	5.68	5.39	5	5.23
Inventory Turnover (Average Inventory)	2.63	2.4	2.33	1.97	1.81
Short Term Liquidity
Current Ratio	1.8	2.31	1.96	2.03	2.2
Quick Ratio	1.16	1.57	1.25	1.12	1.22
Operating Cash Flow to Current Liabilities	0.63	0.85	0.42	0.41	0.59
Days Sales Outstanding (Average Receivables)	67.49	64.24	67.66	72.94	69.93
Days Outstanding Inventory (Average Inventory)	139.02	152.01	156.73	185.69	201.79
Average Days Payable Outstanding	54.32	54.15	54.71	54.53	51.95
Cash Conversion Cycle (Average Days)	152.2	162.1	169.68	204.1	219.77
Long Term Solvency
Total Debt/Equity	19.4	14.57	13.87	13.83	11.65
Total Debt / Total Capital	16.25	12.72	12.18	12.15	10.44
LT Debt/Equity	14.2	11.43	8.74	9.47	8.29
Long-Term Debt / Total Capital	11.89	9.98	7.68	8.32	7.43
Total Liabilities / Total Assets	36.83	31.24	29.76	28.65	27.02
EBIT / Interest Expense	25.41	88.02	149.51	129.32	39.87
EBITDA / Interest Expense	34.08	113.4	205.59	201.66	61.38
(EBITDA - Capex) / Interest Expense	22.56	81.52	135.66	124.77	39.77
Total Debt / EBITDA	0.59	0.45	0.6	0.58	0.5
Net Debt / EBITDA	0.11	-0.33	-0.06	0.19	0.04
Total Debt / (EBITDA - Capex)	0.89	0.62	0.91	0.94	0.77
Net Debt / (EBITDA - Capex)	0.17	-0.46	-0.08	0.3	0.06
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	16.58	8.27	6.31	2.38	8.31
Gross Profit, 1 Yr. Growth %	19.58	11.97	0.39	2.42	7.68
EBITDA, 1 Yr. Growth %	44.66	26.05	-19.01	0.61	10.54
EBITA, 1 Yr. Growth %	53.2	30.19	-17.57	-0.62	6.99
EBIT, 1 Yr. Growth %	57.7	30.78	-24.65	-7.18	12.11
Earnings From Cont. Operations, 1 Yr. Growth %	49.31	48.55	-26.35	-26.74	31.69
Net Income, 1 Yr. Growth %	48.24	48.64	-24.74	-20.96	20.86
Normalized Net Income, 1 Yr. Growth %	58.55	35.34	-22.51	0.14	2.17
Diluted EPS Before Extra, 1 Yr. Growth %	48.26	48.39	-24.51	-21.2	20.93
Accounts Receivable, 1 Yr. Growth %	8.3	-1.22	25.31	-1.55	8.74
Inventory, 1 Yr. Growth %	9.54	17.11	18.9	23.24	14.18
Net Property, Plant and Equip., 1 Yr. Growth %	4.23	14.62	11.85	9.94	12.59
Total Assets, 1 Yr. Growth %	3.86	17.54	12.63	1.4	9.71
Tangible Book Value, 1 Yr. Growth %	31.45	48.94	6.67	16.53	18.13
Common Equity, 1 Yr. Growth %	10.31	28.46	15.81	4.11	12.06
Cash From Operations, 1 Yr. Growth %	42.88	39.17	-42.39	-6.25	49.82
Capital Expenditures, 1 Yr. Growth %	1.83	4.54	-1.17	18	2.22
Levered Free Cash Flow, 1 Yr. Growth %	178.45	39.73	-56.88	-22.77	95.59
Unlevered Free Cash Flow, 1 Yr. Growth %	161.02	34.34	-56.85	-22.4	89.85
Dividend Per Share, 1 Yr. Growth %	226.32	37.1	0	0	5.88
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	13.48	12.35	7.29	4.33	5.3
Gross Profit, 2 Yr. CAGR %	16.04	15.71	7.02	1.4	5.02
EBITDA, 2 Yr. CAGR %	23.86	35.04	1.09	-7.62	5.46
EBITA, 2 Yr. CAGR %	27.73	41.22	2.6	-9.49	3.11
EBIT, 2 Yr. CAGR %	29.81	43.61	0.04	-16.37	2.01
Earnings From Cont. Operations, 2 Yr. CAGR %	25.57	48.93	4.6	-26.54	-1.77
Net Income, 2 Yr. CAGR %	25.56	48.44	5.77	-22.87	-2.26
Normalized Net Income, 2 Yr. CAGR %	31.5	46.49	3.2	-11.91	1.15
Diluted EPS Before Extra, 2 Yr. CAGR %	25.36	48.32	5.84	-22.87	-2.38
Accounts Receivable, 2 Yr. CAGR %	10.26	3.43	11.26	11.07	3.47
Inventory, 2 Yr. CAGR %	13.75	13.26	16.64	21.05	18.62
Net Property, Plant and Equip., 2 Yr. CAGR %	9.02	9.3	13.22	10.89	11.25
Total Assets, 2 Yr. CAGR %	5.87	10.49	14.91	6.87	5.47
Tangible Book Value, 2 Yr. CAGR %	30.99	39.93	25.71	11.49	17.33
Common Equity, 2 Yr. CAGR %	12.29	19.04	21.76	9.8	8.01
Cash From Operations, 2 Yr. CAGR %	20.74	41.01	-9.71	-26.51	18.51
Capital Expenditures, 2 Yr. CAGR %	10.71	3.18	1.64	7.99	9.82
Levered Free Cash Flow, 2 Yr. CAGR %	11.64	97.07	-22.96	-36	20.13
Unlevered Free Cash Flow, 2 Yr. CAGR %	11.59	87.26	-24.43	-35.91	21.38
Dividend Per Share, 2 Yr. CAGR %	33.1	111.51	17.09	0	2.9
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	10.87	11.72	10.3	5.63	5.64
Gross Profit, 3 Yr. CAGR %	13.11	14.67	11.05	5.47	3.45
EBITDA, 3 Yr. CAGR %	18.8	24.59	13.92	2.5	-1.92
EBITA, 3 Yr. CAGR %	21.85	28.54	17.27	1.52	-4.3
EBIT, 3 Yr. CAGR %	22.32	30.13	16.43	-2.43	-7.79
Earnings From Cont. Operations, 3 Yr. CAGR %	19.24	32.8	17.78	-7.11	-10.76
Net Income, 3 Yr. CAGR %	19.31	32.83	18.37	-4.02	-10.41
Normalized Net Income, 3 Yr. CAGR %	23.34	32.77	19.08	2.17	-7.45
Diluted EPS Before Extra, 3 Yr. CAGR %	19.27	32.61	18.43	-4.07	-10.4
Accounts Receivable, 3 Yr. CAGR %	9.13	6.29	10.26	6.81	10.29
Inventory, 3 Yr. CAGR %	12.53	14.86	14.22	18.8	18.71
Net Property, Plant and Equip., 3 Yr. CAGR %	14.52	10.85	10.14	12.12	11.45
Total Assets, 3 Yr. CAGR %	9.52	9.62	11.1	10.22	7.81
Tangible Book Value, 3 Yr. CAGR %	16.63	36.72	27.6	22.57	13.66
Common Equity, 3 Yr. CAGR %	11.85	17.44	17.82	15.56	10.55
Cash From Operations, 3 Yr. CAGR %	19.53	26.59	5.21	-8.57	-6.82
Capital Expenditures, 3 Yr. CAGR %	14.78	8.62	1.71	6.83	6.03
Levered Free Cash Flow, 3 Yr. CAGR %	33.12	20.24	18.16	-17.39	-8.53
Unlevered Free Cash Flow, 3 Yr. CAGR %	31.86	18.71	14.24	-18.38	-7.96
Dividend Per Share, 3 Yr. CAGR %	22.17	34.42	64.77	11.09	1.92
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	9.68	9.93	9.42	8.7	8.27
Gross Profit, 5 Yr. CAGR %	12.13	12.27	10.64	9.58	8.6
EBITDA, 5 Yr. CAGR %	15.72	18.01	11.37	10.56	11.48
EBITA, 5 Yr. CAGR %	17.45	20.29	13.75	11.28	11.39
EBIT, 5 Yr. CAGR %	18.69	21.88	12.87	9.38	10.43
Earnings From Cont. Operations, 5 Yr. CAGR %	29.56	27.26	13.16	4.8	9.53
Net Income, 5 Yr. CAGR %	29.63	27.4	13.7	6.87	9.64
Normalized Net Income, 5 Yr. CAGR %	20	23.64	14.85	13.02	11.56
Diluted EPS Before Extra, 5 Yr. CAGR %	29.58	27.3	13.7	6.76	9.62
Accounts Receivable, 5 Yr. CAGR %	6.08	4.86	9.97	8.18	7.49
Inventory, 5 Yr. CAGR %	8.78	9.43	14.15	16.75	15.96
Net Property, Plant and Equip., 5 Yr. CAGR %	13.25	10.77	14	10.87	10.59
Total Assets, 5 Yr. CAGR %	7.21	8.8	11.65	8.46	8.82
Tangible Book Value, 5 Yr. CAGR %	19.67	25.5	20.18	25.87	23.38
Common Equity, 5 Yr. CAGR %	10.22	14.04	15.71	14.24	13.79
Cash From Operations, 5 Yr. CAGR %	13.46	19.3	6.84	2.18	10.35
Capital Expenditures, 5 Yr. CAGR %	5.91	4.48	9.33	8.36	4.88
Levered Free Cash Flow, 5 Yr. CAGR %	19.5	30.88	6.93	-6.84	23.97
Unlevered Free Cash Flow, 5 Yr. CAGR %	18.62	28.69	5.54	-7.51	21.92
Dividend Per Share, 5 Yr. CAGR %	13.22	20.59	20.11	19.42	36.49